NASDAQ: GEMP Investor Alert: Investigation of Certain Directors of Gemphire Therapeutics Inc.
January 30, 2019 at 11:26 AM EST
San Diego, CA -- (SBWIRE) -- 01/30/2019 -- An investigation on behalf of investors in Gemphire Therapeutics Inc. (NASDAQ: GEMP) shares over potential wrongdoing at Gemphire Therapeutics Inc. was announced and NASDAQ: GEMP stockholders should contact the Shareholders Foundation.
